Prostate Cancer - Results from #25440

Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments - Abstract May 6, 2011

Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer - Abstract May 6, 2011

Robotic palpation-based mechanical property mapping for diagnosis of prostate cancer - Abstract May 6, 2011

Haplotype analysis of prostate stem cell antigen and association with prostate cancer risk - Abstract May 6, 2011

Routine dual-color immunostaining with a 3-antibody cocktail improves the detection of small cancers in prostate needle biopsies - Abstract May 6, 2011

The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation - Abstract May 6, 2011

American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer - Abstract May 6, 2011

Which comorbidity classification best fits elderly candidates for radical prostatectomy? - Abstract May 6, 2011

EAU 2011 - Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on saturation biopsy scheme - Session Highlights May 6, 2011

EAU 2011 - The value of computed tomography in detecting prostate cancer lymph node metastasis is negligible even in contemporary patients with very high risk of nodal involvement - Session Highlights May 6, 2011

Prostate needle biopsies: Interobserver variation and clinical consequences of histopathological re-evaluation - Abstract May 5, 2011

Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: A population-based study - Abstract May 5, 2011

Bone scan overuse in staging of prostate cancer: An analysis of a Veterans Affairs cohort - Abstract May 5, 2011

Low-dose-rate brachytherapy as salvage treatment of local prostate cancer recurrence after radical prostatectomy - Abstract May 5, 2011

Gleason Pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation - Abstract May 5, 2011

Transurethral resection biopsy as part of a saturation biopsy protocol: A cohort study and review of the literature - Abstract May 5, 2011

The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration May 5, 2011

Decision tree-based modeling of androgen pathway genes and prostate cancer risk - Abstract May 5, 2011

Extended sampling at first biopsy improves cancer detection rate: Results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy - Abstract May 5, 2011

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities - Abstract May 4, 2011

Page 1273 of 1305